Did you mean
sous africa

Search results - 19 results

The obesity transition: stages of the global epidemic.

than in children. Many countries in south Asia and sub-Saharan Africa are presently in this stage. In countries in stage 2 of the transition, there has been a large increase in the prevalence among ...

The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.

with rifampicin-resistant tuberculosis (RR- TB), especially in South Africa where Xpert is now the initial diagnostic for individuals with TB symptoms. We hypothesized that a proportion of RR- TB ...

Foot-and-mouth disease virus serotype SAT1 in cattle, Nigeria.

The knowledge of foot-and-mouth disease virus (FMDV) dynamics and epidemiology in Nigeria and the West Africa subregion is important to support local and regional control plans and international risk ...

Outbreak investigations and molecular characterization of foot-and-mouth disease viruses circulating in south-west Niger.

provides epidemiological information about FMD in the south-western part of Niger and highlights the complex transboundary nature of FMD in Africa. These findings may help to develop effective control and ...

Mycobacterium tuberculosis-associated synthetic mycolates differentially exert immune stimulatory adjuvant activity

School South Africa SOUTH-AFRICA structure study Synthetic Tuberculosis United Kingdom United-kingdom Universities university Abstract: Mycolic acids (MA s) are highly hydrophobic long-chain alpha-alkyl ...

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage20

POPULATION population-size Project public public health Public-health Quality Research Research Support Russia SB- IM School Science Selection serum Service Size SOCIAL South Africa SOUTH-AFRICA Spain Spread ...

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.

double-blind, placebo-controlled, phase 2 trial of MVA85A in adults infected with HIV-1, at two clinical sites, in Cape Town, South Africa and Dakar, Senegal. Eligible participants were aged 18-50 years, had no ...

QR code

QR code for this page URL